GMDA

Gamida Cell Ltd
1.75
0.06 (3.55%)
Company Name Stock Ticker Symbol Market Type
Gamida Cell Ltd GMDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.06 3.55% 1.75 08:10:21
Open Price Low Price High Price Close Price Prev Close
1.69
more quote information »

Recent News

Date Time Source Heading
2/07/20239:17IHNWFeaturedAmerican Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Facility PHOENIX, AZ (January 7,
1/30/202307:03EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
1/30/202307:01EDGARCurrent Report Filing (8-k)
1/23/202306:04EDGARNotice of Effectiveness (effect)
1/20/202316:32EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/19/202316:44EDGARCurrent Report Filing (8-k)
1/10/202317:13EDGARProxy Statement (definitive) (def 14a)
1/09/202312:16EDGARCurrent Report Filing (8-k)
12/30/202217:17EDGARProxy Statement - Notice of Shareholders Meeting..
12/12/202213:11TRMNAnalysts’ Top Healthcare Picks: Crispr Therapeutics AG..
12/12/202207:16EDGARCurrent Report Filing (8-k)
12/12/202207:00BWGamida Cell Announces Closing of $25 Million Financing With..
11/23/202208:00BWGamida Cell to Present Corporate Highlights at Multiple..
11/22/202216:37EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202213:05TRMNJMP Securities Remains a Buy on Gamida Cell (GMDA)
11/22/202210:17TRMNGMDA Down After FDA Extends Review For Lead Candidate
11/22/202209:55TRMNNeedham Sticks to Their Buy Rating for Gamida Cell (GMDA)
11/21/202216:52BWGamida Cell Provides Regulatory Update on Omidubicel
11/15/202216:21EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
11/15/202206:45TRMNH.C. Wainwright Sticks to Its Buy Rating for Gamida Cell..
11/14/202207:16EDGARCurrent Report Filing (8-k)
11/14/202207:00BWGamida Cell Reports Third Quarter 2022 Financial Results and..
11/10/202208:00BWGamida Cell to Present Corporate Highlights at the Jefferies..
11/07/202208:00BWGDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising..
11/03/202209:07BWGamida Cell Announces Omidubicel Data To Be Presented as an..
10/10/202207:00BW Gamida Cell to Present Corporate Highlights at 2022 Cell &..
10/04/202216:41EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
9/30/202216:03EDGARCurrent Report Filing (8-k)
9/29/202216:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/29/202207:00BWLong-Term Data from Omidubicel Phase 3 Trial Demonstrates..
9/28/202200:08BWGamida Cell Announces Pricing of Approximately $20 Million..
9/27/202217:04EDGARCurrent Report Filing (8-k)
9/27/202217:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/27/202216:06BWGamida Cell Announces Launch of Public Offering of Ordinary..
9/20/202216:11EDGARStatement of Changes in Beneficial Ownership (4)
9/20/202216:08EDGARInitial Statement of Beneficial Ownership (3)
9/19/202209:45TRMNJMP Securities Sticks to Their Buy Rating for Gamida Cell..
9/19/202207:07EDGARCurrent Report Filing (8-k)
9/19/202207:00BWGamida Cell Appoints Abigail L. Jenkins as President and..
9/12/202208:00BWGamida Cell Presents Data Demonstrating the Impact of..
8/16/202206:25TRMNH.C. Wainwright Remains a Buy on Gamida Cell (GMDA)
8/15/202215:05TRMNJMP Securities Sticks to Their Buy Rating for Gamida Cell..
8/15/202211:35TRMNNeedham Reaffirms Their Buy Rating on Gamida Cell (GMDA)
8/15/202207:35EDGARQuarterly Report (10-q)
8/15/202207:21EDGARCurrent Report Filing (8-k)
8/15/202207:00BWGamida Cell Reports Second Quarter 2022 Financial Results..
8/10/202216:59EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202210:25TRMNH.C. Wainwright Keeps Their Buy Rating on Gamida Cell (GMDA)